News
BioNTech SE (NASDAQ:BNTX) just released its full-year report and things are looking bullish. Results overall were credible, with revenues arriving 3.9% better than analyst forecasts at €2.8b ...
Deep-pocketed investors have adopted a bearish approach towards BioNTech (NASDAQ:BNTX), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga ...
Diving into Analyst Ratings: An In-Depth Exploration The standing of BioNTech among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below ...
U.S.-listed shares of BioNTech fell Monday, as the COVID-19 vaccine maker’s soft sales outlook offset better-than-expected quarterly results. The German company said it expects 2025 total ...
BioNTech is expanding its oncology pipeline with FixVac, iNeST, and BNT327 for individualized cancer treatments. However, note that some regulatory and legal challenges, including a Moderna patent ...
March 10 (Reuters) - German COVID-19 vaccine maker BioNTech (22UAy.DE), opens new tab on Monday said that its 2025 revenues would likely fall to between 1.7 billion euros ($1.85 billion ...
BioNTech SE posted a smaller profit in its latest quarter as sales slumped under reduced demand for its Covid-19 vaccines. The German developer of RNA vaccines and immunotherapies logged a profit ...
Hosted on MSN3mon
Penn’s royalties from Pfizer-BioNTech COVID-19 vaccine grow to at least $2 billion after new settlementPenn will receive $467 million under a settlement with German drug manufacturer BioNTech, which partnered with Pfizer to develop a COVID vaccine that relied on mRNA technology developed at the ...
Among the largest underlying components of FNDF, in trading today Medtronic PLC (Symbol: MDT) is up about 1.3%, BioNTech SE (Symbol: BNTX) is down about 6.9%, and Ferguson Enterprises Inc (Symbol ...
Backers, including BioNTech, have committed around one-third of the targeted IPO haul. China’s DualityBio filed to go public in Hong Kong last year but let that submission lapse. Having added ...
The general mood among these heavyweight investors is divided, with 25% leaning bullish and 62% bearish. Among these notable options, 6 are puts, totaling $283,790, and 2 are calls, amounting to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results